Suppr超能文献

一项评估体育活动与rs738409基因多态性对日本老年普通人群非酒精性脂肪性肝病风险可能的联合作用的初步研究。

A Pilot Study Assessing the Possible Combined Effect of Physical Activity and rs738409 Polymorphism on the Risk for Non-Alcoholic Fatty Liver Disease in the Japanese Elderly General Population.

作者信息

Muto Narumi, Oniki Kentaro, Kudo Miku, Obata Yui, Sakamoto Yuki, Tokumaru Naoto, Izuka Tomoko, Watanabe Takehisa, Otake Koji, Ogata Yasuhiro, Saruwatari Junji

机构信息

Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Departments of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

出版信息

Diabetes Metab Syndr Obes. 2020 Feb 12;13:333-341. doi: 10.2147/DMSO.S217597. eCollection 2020.

Abstract

PURPOSE

The patatin-like phospholipase domain containing protein 3 () rs738409 polymorphism (c.444C>G) is the most well-known genetic risk factor for non-alcoholic fatty liver disease (NAFLD), but whether or not physical activity influences the association between the genotype and risk of NAFLD is unclear.

PATIENTS AND METHODS

A retrospective longitudinal analysis was conducted among 352 Japanese subjects. Each type of physical activity was assigned a metabolic equivalent (MET), and the subjects were classified into sedentary, low or high groups using the "METS*T" (METs × hours per week) value of 5 or 21 as a threshold.

RESULTS

Among the G/G genotype carriers, the high and low METST groups had a lower risk of NAFLD than the sedentary METST group (odds ratio [95% confidence interval]: 0.14 [0.02-0.99] and 0.16 [0.03-1.04], respectively). Furthermore, the C/C or C/G genotype carriers showed no significant difference in the risk of NAFLD among the three METS*T groups.

CONCLUSION

The rs738409 genotype may be associated with the beneficial effects of physical activity on the risk of NAFLD among elderly Japanese individuals. Further comprehensive investigations are therefore needed to verify the preliminary results.

摘要

目的

含patatin样磷脂酶结构域蛋白3()rs738409多态性(c.444C>G)是非酒精性脂肪性肝病(NAFLD)最著名的遗传危险因素,但体力活动是否会影响该基因型与NAFLD风险之间的关联尚不清楚。

患者与方法

对352名日本受试者进行了回顾性纵向分析。为每种体力活动分配一个代谢当量(MET),并以“METS*T”(METs×每周小时数)值5或21为阈值将受试者分为久坐、低或高组。

结果

在G/G基因型携带者中,高和低METST组的NAFLD风险低于久坐的METST组(优势比[95%置信区间]:分别为0.14[0.02 - 0.99]和0.16[0.03 - 1.04])。此外,C/C或C/G基因型携带者在三个METS*T组中的NAFLD风险无显著差异。

结论

rs738409基因型可能与体力活动对日本老年个体NAFLD风险的有益影响有关。因此,需要进一步进行全面调查以验证初步结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f5/7024805/884290c8c463/DMSO-13-333-g0001.jpg

相似文献

4
The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity.
Pediatr Gastroenterol Hepatol Nutr. 2021 Sep;24(5):455-469. doi: 10.5223/pghn.2021.24.5.455. Epub 2021 Sep 8.
6
Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome.
J Trace Elem Med Biol. 2017 Jan;39:100-107. doi: 10.1016/j.jtemb.2016.08.006. Epub 2016 Aug 20.
7
Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis.
Clin Gastroenterol Hepatol. 2013 Dec;11(12):1667-72. doi: 10.1016/j.cgh.2013.06.025. Epub 2013 Jul 18.
8
PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease.
World J Clin Cases. 2018 Aug 16;6(8):167-175. doi: 10.12998/wjcc.v6.i8.167.
9
A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
J Hepatol. 2020 Jun;72(6):1070-1081. doi: 10.1016/j.jhep.2020.01.029. Epub 2020 Mar 5.
10
Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Ann Hepatol. 2019 May-Jun;18(3):466-471. doi: 10.1016/j.aohep.2018.10.004. Epub 2019 Apr 18.

引用本文的文献

1

本文引用的文献

1
Obesity and nonalcoholic fatty liver disease: current perspectives.
Diabetes Metab Syndr Obes. 2018 Sep 25;11:533-542. doi: 10.2147/DMSO.S146339. eCollection 2018.
3
Fighting the fatty liver.
Nature. 2017 Oct 11;550(7675):S102-S103. doi: 10.1038/550S102a.
4
Treatment of NAFLD with diet, physical activity and exercise.
J Hepatol. 2017 Oct;67(4):829-846. doi: 10.1016/j.jhep.2017.05.016. Epub 2017 May 23.
7
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review.
J Hepatol. 2017 Jan;66(1):142-152. doi: 10.1016/j.jhep.2016.08.023. Epub 2016 Sep 14.
8
Nonalcoholic fatty liver disease in Asia: emerging perspectives.
J Gastroenterol. 2017 Feb;52(2):164-174. doi: 10.1007/s00535-016-1264-3. Epub 2016 Sep 16.
9
Obesity in older adults and life expectancy with and without cardiovascular disease.
Int J Obes (Lond). 2016 Oct;40(10):1535-1540. doi: 10.1038/ijo.2016.94. Epub 2016 May 10.
10
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验